Transforming

Liver Care

Through AI

logo karyon-bio-omega.com

Empowering Precision Liver Health

liver

About Us

PRO HEALTH

At Karyon Bio, we revolutionize liver disease management with our innovative, AI-powered biomarker and drug discovery solutions.

hero

By seamlessly integrating multi-omics data, clinical insights, literature mining, and advanced Imaging techniques, our non-invasive platform offers early diagnosis, accurate prognosis, and personalized treatment strategies for NAFLD/NASH and other liver disorder

Our proprietary AI algorithm technology detects NAFLD at its inception, predicts disease progression, and identifies tailored therapeutic options. With a commitment to precision medicine, Karyon Bio is at the forefront of transforming liver care, providing patients and healthcare providers with the tools they need for better health outcomes.

Why Karyon Bio

Chronic liver disease is the only top ten global killer on the rise

"Liver disease is the third leading cause of premature death.” UK Health Security Agency, July 2021

Without effective therapies, the only resort for many patients remains a liver transplant. However the supply of healthy donor organs cannot meet what’s required, with minorities disproportionately disadvantaged. 

An estimated 20% of patients with NASH will develop cirrhosis, and NASH is predicted to become the leading indication for liver transplants in the US. The mortality rate among patients with NASH is substantially higher than the general population or patients without this inflammatory subtype of NAFLD

Click For Lab Report
90 percent SVG

Empowering Precision Liver Health

This project aims to leverage advanced technologies to enhance liver health through precise and personalized medical insights and solutions.

Zoom In Image
90 percent SVG

Global prevalence of NAFLD is 25.24% (95% CI: 22.10-28.65) with highest prevalence in the Middle East and South America and lowest in Africa.

Click For Lab Report

Why Partner with Karyon Bio?

INNOVATIVE TECHNOLOGY

INNOVATIVE TECHNOLOGY

Diagnostic Labs

Diagnostic Labs

Hospital

Hospital

Our Team

Srinivas Thirunagari, Founder & CEO

Founder & CEO

Srinivas Thirunagari, Founder & CEO

Srinivas Thirunagari, Founder & CEO Srinivas leverages over two decades of experience in computer vision and AI. With a strong foundation in Biomedical Engineering and Computer Science, Srinivas has expertise that spans AI-driven diagnostics. Read More

linkedin
Dr. Eckart Bindewald, Principal Scientist - AI/ML

Principal Scientist - AI/ML

Dr. Eckart Bindewald, Principal Scientist - AI/ML

Dr. Eckart Bindewald, Principal Scientist - AI/ML Dr. Eckart Bindewald is a seasoned bioinformatics and computational biology expert with over two decades of experience developing cutting-edge AI/ML algorithms for biomedical research. Read More

linkedin
Dr. Dhatchana Moorthy, Principal Scientist - Biomarker Research

Principal Scientist - Biomarker Research

Dr. Dhatchana Moorthy, Principal Scientist - Biomarker Research

Dr. Dhatchana Moorthy, Principal Scientist - Biomarker Research Dr. Dhatchana Moorthy brings over 25 years of expertise in drug discovery, biomarker research, and biotherapeutics, with a focus on gene therapy and targeted small molecules. Read More

linkedin

Elevate your wealth in biomedical research!

Team up with us today for an unforgettable service experience

Hospital

Labs

Pharma

Clinical

HOSPITAL

Partner with us for an exceptional, personalized service experience that drives success and innovation. Let's ignite progress together.

Partner with us to advance cutting-edge biomedical research and enhance patient care together.

We would love to hear from you

Feel free to reach out if you want to collaborate with us, or simply have a chat.

Get In Touch

Contact us

  • karyonbio@gmail.com
  • +91 9985854689
  • 855 Maude Ave, Mountain View, CA 94043

Follow us

All rights reserved Privacy Policy